WO2012174622A8 - Extrato vegetal obtido de kielmeyera aureovinosa com atividade antibiótica, composto químico isolado, composições compreendendo os mesmos, seus usos e métodos de prevenção e tratamento de infecções bacterianas - Google Patents

Extrato vegetal obtido de kielmeyera aureovinosa com atividade antibiótica, composto químico isolado, composições compreendendo os mesmos, seus usos e métodos de prevenção e tratamento de infecções bacterianas Download PDF

Info

Publication number
WO2012174622A8
WO2012174622A8 PCT/BR2012/000190 BR2012000190W WO2012174622A8 WO 2012174622 A8 WO2012174622 A8 WO 2012174622A8 BR 2012000190 W BR2012000190 W BR 2012000190W WO 2012174622 A8 WO2012174622 A8 WO 2012174622A8
Authority
WO
WIPO (PCT)
Prior art keywords
plant extract
same
compositions
aureovinosa
kielmeyera
Prior art date
Application number
PCT/BR2012/000190
Other languages
English (en)
French (fr)
Other versions
WO2012174622A1 (pt
Inventor
Antônio PAES DE CARVALHO
Otavio PADULA DE MIRANDA
Lisieux DE SANTANA JULIÃO
Giselle MARIE ACCIOLY MACHADO DE OLIVEIRA
Mário GOMES
Original Assignee
Extracta Moléculas Naturais S/A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Extracta Moléculas Naturais S/A filed Critical Extracta Moléculas Naturais S/A
Priority to EP12802772.9A priority Critical patent/EP2735311A4/en
Priority to CA2869331A priority patent/CA2869331A1/en
Priority to BR112013033102A priority patent/BR112013033102A2/pt
Priority to US14/127,870 priority patent/US20150335691A1/en
Publication of WO2012174622A1 publication Critical patent/WO2012174622A1/pt
Publication of WO2012174622A8 publication Critical patent/WO2012174622A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A presente invenção se refere a um extrato vegetal obtido de Kielmeyera aureovinosa que possui acentuada atividade antibiótica. Em uma segunda modalidade, a invenção descreve um novo composto químico isolado do mesmo, bem como variações deste. Em outras modalidades, a presente invenção fornece composições fitoterápicas compreendendo o referido extrato vegetal, assim como composições farmacêuticas veterinárias compreendendo o composto isolado e variações do mesmo. Adicionalmente, são providos usos do extrato vegetal, compostos químicos e composições compreendendo os mesmos para a preparação de medicamentos para tratamento de infecções bacterianas e métodos de prevenção ou tratamento das mesmas.
PCT/BR2012/000190 2011-06-22 2012-06-25 Extrato vegetal obtido de kielmeyera aureovinosa com atividade antibiótica, composto químico isolado, composições compreendendo os mesmos, seus usos e métodos de prevenção e tratamento de infecções bacterianas WO2012174622A1 (pt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP12802772.9A EP2735311A4 (en) 2011-06-22 2012-06-25 PLANT EXTRACT FROM KIELMEYERA AUREOVINOSA WITH ANTIBIOTIC EFFECT, INSULATED CHEMICAL COMPOUND, COMPOSITIONS THEREOF, USES THEREOF, AND METHOD FOR THE PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS
CA2869331A CA2869331A1 (en) 2011-06-22 2012-06-25 Plant extract obtained from kielmeyera aureovinosa which has antibiotic activity, isolated chemical compound, compositions comprising same, uses thereof and methods for preventingand treating bacterial infections
BR112013033102A BR112013033102A2 (pt) 2011-06-22 2012-06-25 extrato vegetal obtido de kielmeyera aureovinosa com atividade antibiótica, composto químico isolado, composições compreendendo os mesmos, seus usos e métodos de prevenção ou tratamento de infecções bacterianas
US14/127,870 US20150335691A1 (en) 2011-06-22 2012-06-25 Plant extract obtained from kielmeyera aureovinosa which has antibiotic activity, isolated chemical compound, compositions comprising same, uses thereof and methods for preventing and treating bacterial infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161500077P 2011-06-22 2011-06-22
US61/500,077 2011-06-22

Publications (2)

Publication Number Publication Date
WO2012174622A1 WO2012174622A1 (pt) 2012-12-27
WO2012174622A8 true WO2012174622A8 (pt) 2014-01-09

Family

ID=47421933

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2012/000190 WO2012174622A1 (pt) 2011-06-22 2012-06-25 Extrato vegetal obtido de kielmeyera aureovinosa com atividade antibiótica, composto químico isolado, composições compreendendo os mesmos, seus usos e métodos de prevenção e tratamento de infecções bacterianas

Country Status (5)

Country Link
US (1) US20150335691A1 (pt)
EP (1) EP2735311A4 (pt)
BR (1) BR112013033102A2 (pt)
CA (1) CA2869331A1 (pt)
WO (1) WO2012174622A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112273385A (zh) * 2020-11-25 2021-01-29 宿迁市产品质量监督检验所 没食子酸辛酯与丙烯醛的加合产物在制备抑菌剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112273385A (zh) * 2020-11-25 2021-01-29 宿迁市产品质量监督检验所 没食子酸辛酯与丙烯醛的加合产物在制备抑菌剂中的应用

Also Published As

Publication number Publication date
EP2735311A4 (en) 2015-01-14
US20150335691A1 (en) 2015-11-26
CA2869331A1 (en) 2012-12-27
EP2735311A1 (en) 2014-05-28
WO2012174622A1 (pt) 2012-12-27
BR112013033102A2 (pt) 2017-01-24

Similar Documents

Publication Publication Date Title
WO2014097151A3 (en) Autotaxin inhibitors
EA021522B9 (ru) Противопаразитарные дигидроазоловые соединения и содержащие их композиции
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
PH12016500003A1 (en) Compounds and compositions as inhibitors of mek
WO2014048940A3 (en) Nitrogen-containing heterocyclic compounds for plant disease control
WO2014206419A3 (en) Compositions comprising fermented seaweed and/or algae
MX2014001599A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
JO3611B1 (ar) سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
WO2014121764A3 (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX2015001834A (es) Nuevos compuestos antibacterianos.
MX2015001835A (es) Nuevos compuestos antibacterianos.
WO2012155226A8 (pt) Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos
WO2012116254A3 (en) Chrysophaentin analogs that inhibit ftsz protein
EP3006434A4 (en) Novel compound derived from plant of genus quamoclit and composition containing same as active ingredient for preventing or treating diabetes
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
WO2012174622A8 (pt) Extrato vegetal obtido de kielmeyera aureovinosa com atividade antibiótica, composto químico isolado, composições compreendendo os mesmos, seus usos e métodos de prevenção e tratamento de infecções bacterianas
MX2015015251A (es) Derivados de la quinolona.
WO2012088568A8 (pt) Associação farmacêutica fitoterápica de lippia salviifolia e lippia sidoides, composição farmacéutica fitoterápica, processo de preparação de composição farmacêutica fitoterápica e seus usos veterinários
WO2011046905A3 (en) Pharmaceutical compositions
WO2013028615A3 (en) Novel cyclosporin derivatives for the treatment and prevention of viral infections
WO2011106630A3 (en) Chrysophaentin antimicrobial compounds that inhibit ftsz protein
WO2014096300A3 (en) Antibacterial compounds
WO2012096463A3 (ko) 복합 생약 추출물을 유효성분으로 함유하는 알러지성 또는 비알러지성 피부 질환의 예방 및 개선용 조성물 및 이의 용도
WO2010139411A3 (de) 17β-ALKYL-17α-OXY-ESTRATRIENE

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12802772

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2012802772

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012802772

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 14127870

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013033102

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2869331

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 112013033102

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20131220